Recital 1, Regulation (EU) 2024/2633

In forcesince 8 Oct 2024

For azoxystrobin, famoxadone, flutriafol, mandipropamid, and mefentrifluconazole, maximum residue levels (‘MRLs’) were set in Annex II to Regulation (EC) No 396/2005.